Svetlana Protsenko

Suggest Changes
Learn More
LBA4001 Background: HER2 amplification is common in upper GI tract (UGIT) adenocarcinomas and inhibition improves clinical outcomes. Lapatinib ditosylate (L), a dual anti EGFR and anti HER2 tyrosine(More)
G.G. Steger1, A. Dominguez2, O. Switsers3, N. Dobrovolskaya4, F. Giotta5, I. Glogowska6, N. Tubiana-Mathieu7, M. Pecherstorfer8, A. Ardizzoia9, P. Bougnoux10, M. Blasinska-Morawiec11, C. Veyret12, S.(More)
  • 1